"I enjoyed your talk, but...": Evidence-based medicine and the scientific foundation of the American Venous Forum

Journal of Vascular Surgery

Volumn 49, Issue 1, 2009, Pages 244-248

  Meissner, Mark H ^a  

^a UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL PRACTICE; CLINICAL TRIAL; DEVICE; EDITORIAL; EVIDENCE BASED PRACTICE; HEALTH CARE ORGANIZATION; HUMAN; OUTCOME ASSESSMENT; PHYSICIAN; PRIORITY JOURNAL; QUALITY CONTROL; UNITED STATES; VEIN SURGERY;

BIOLOGICAL MARKERS; CARDIOVASCULAR AGENTS; CLINICAL TRIALS AS TOPIC; EVIDENCE-BASED MEDICINE; HUMANS; REPRODUCIBILITY OF RESULTS; RESEARCH DESIGN; SOCIETIES, MEDICAL; TREATMENT OUTCOME; UNITED STATES; VASCULAR SURGICAL PROCEDURES; VEINS;

EID: 58549107559     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvs.2008.08.029     Document Type: Editorial

References (42)

1. Heit J.A. The epidemiology of venous thromboembolism in the community: implications for prevention and management. J Thromb Thrombolysis 21 (2006) 23-29
2. Tsai S., Dubovoy A., Wainess R., Upchurch Jr. G.R., Wakefield T.W., and Henke P.K. Severe chronic venous insufficiency: magnitude of the problem and consequences. Ann Vasc Surg 19 (2005) 705-711
3. O'Donnell Jr. T.F. Lessons from the past guide the future: is history truly circular?. J Vasc Surg 30 (1999) 775-786
4. Montaner J.S., O'Shaughnessy M.V., and Schechter M.T. Industry-sponsored clinical research: a double-edged sword. Lancet 358 (2001) 1893-1895
5. Gluud L.L. Bias in clinical intervention research. Am J Epidemiol 163 (2006) 493-501
6. Montori V.M., Jaeschke R., Schunemann H.J., Bhandari M., Brozek J.L., Devereaux P.J., et al. Users' guide to detecting misleading claims in clinical research reports. BMJ 329 (2004) 1093-1096
7. Newburger A.E. Cosmetic medical devices and their FDA regulation. Arch Dermatol 142 (2006) 225-228
8. Nygaard I. What does "FDA Approved" mean for medical devices. Obstet Gynecol 111 (2008) 4-6
9. Sackett D.L. Evidence-based medicine. Spine 23 (1998) 1085-1086
10. Grade Working Group. Grading quality of evidence and strength of recommendation. BMJ 328 (2004) 1490-1494
11. Ioannidis J.P.A., and Haidich A.-B. Any casualties in the clash of randomised and observation evidence?. BMJ 322 (2001) 879-880
12. Strandness D.E. Randomized clinical trials: enough bang for the buck?. J Vasc Surg 13 (1991) 544-548
13. Devereaux P.J., Clarke M., Montori V.M., Cook D.J., Yusuf S., Sackett D.L., et al. Need for expertise based randomized controlled trials. BMJ 330 (2005) 88
14. Concato J., Shah N., and Horwitz R.I. Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med 342 (2000) 1887-1892
15. Benson K., and Hartz A.J. A comparison of observational studies and randomized, controlled trials. New Engl J Med 342 (2000) 1878-1886
16. Rutherford R.B. Vascular surgery-comparing outcomes. J Vasc Surg 23 (1996) 5-17
17. Ioannidis J.P.A., Haidich A.-B., Pappa M., Pantazis N., Kokori S.I., Tektonidou M.G., et al. Comparison of evidence of treatment effects in randomized and nonrandomized studies. JAMA 286 (2001) 821-830
18. Guyatt G., Gutterman D., Baumann M.H., Addrizzo-Harris D., Hylek E.M., Phillips B., et al. Grading strength of recommendations and quality of evidence in clinical practice guidelines: report from an American College of Chest Physicians task force. Chest 129 (2006) 174-181
19. Gluud C., Brok J., Gong Y., and Koretz R.L. Hepatology may have problems with putative surrogate outcome measures. J Hepatol 46 (2007) 734-742
20. Guyatt G., Montori V., Devereaux P.J., Schunemann H., and Bhandari M. Patients at the center: in our practice, and in our use of language. ACP J Club 140 (2004) A11-A12
21. Fleming T.R., and DeMets D.L. Surrogate endpoints in clinical trials: are we being misled?. Ann Intern Med 125 (1996) 605-613
22. Kassai B., Shah N.R., Leizorovicza A., Cucherat M., Gueyffier F., and Boissel J.-P. The true treatment benefit is unpredictable in clinical trials using surrogate outcome measured with diagnostic tests. J Clin Epidemiol 58 (2005) 1042-1051
23. Connolly S.J. Use and misuse of surrogate outcomes in arrhythmia trials. Circulation 113 (2006) 764-766
24. Grimes D.A., and Schulz K.F. Surrogate endpoints in clinical research: hazardous to your health. Obstet Gynecol 105 (2005) 1114-1118
25. Rutherford R.B., Padberg F.T., Comerota A.J., Kistner R.L., Meissner M.H., and Moneta G.L. Venous severity scoring: an adjunct to venous outcome assessment. J Vasc Surg 31 (2000) 1307-1312
26. Vasquez M.A., Wang J., Mahathanaruk M., Buczkowski G., Sprehe E., and Dosluoglu H.H. The utility of the Venous Clinical Severity Score in 682 limbs treated by radiofrequency saphenous vein ablation. J Vasc Surg 45 (2007) 1008-1014
27. Guex J.J., Zimmet S.E., Boussetta S., Nguyen C., and Taieb C. Construction and validation of a patient-reported outcome dedicated to chronic venous disorders: SQOR-V (specific quality of life and outcome response - venous). J Mal Vasc 32 (2007) 135-147
28. Lamping D.L., Schroter S., Kurz X., Kahn S.R., and Abenhaim L. Evaluation of outcomes in chronic venous disorders of the leg: development of a scientifically rigorous, patient-reported measure of symptoms and quality of life. J Vasc Surg 37 (2003) 410-419
29. Launois R., Reboul-Marty J., and Henry B. Construction and validation of a quality of life questionnaire in chronic lower limb venous insufficiency (CIVIQ). Qual Life Res 5 (1996) 539-554
30. Smith J.J., Garratt A.M., Guest M., Greenhalgh R.M., and Davies A.H. Evaluating and improving health-related quality of life in patients with varicose veins. J Vasc Surg 30 (1999) 710-719
31. de Medeiros C.A., and Luccas G.C. Comparison of endovenous treatment with an 810 nm laser versus conventional stripping of the great saphenous vein in patients with primary varicose veins. Dermatol Surg 31 (2005) 1685-1694
32. Hinchliffe R.J., Ubhi J., Beech A., Ellison J., and Braithwaite B.D. A prospective randomised controlled trial of VNUS closure versus surgery for the treatment of recurrent long saphenous varicose veins. Eur J Vasc Endovasc Surg 31 (2006) 212-218
33. Lurie F., Creton D., Eklof B., Kabnick L.S., Kistner R.L., Pichot O., et al. Prospective randomized study of endovenous radiofrequency obliteration (closure procedure) versus ligation and stripping in a selected patient population (EVOLVeS Study). J Vasc Surg 38 (2003) 207-214
34. Rasmussen L.H., Bjoern L., Lawaetz M., Blemings A., Lawaetz B., and Eklof B. Randomized trial comparing endovenous laser ablation of the great saphenous vein with high ligation and stripping in patients with varicose veins: short-term results. J Vasc Surg 46 (2007) 308-315
35. Rautio T., Ohinmaa A., Perala J., Ohtonen P., Heikkinen T., Wiik H., et al. Endovenous obliteration versus conventional stripping operation in the treatment of primary varicose veins: a randomized controlled trial with comparison of the costs. J Vasc Surg 35 (2002) 958-965
36. Lurie F., Creton D., Eklof B., Kabnick L.S., Kistner R.L., Pichot O., et al. Prospective randomised study of endovenous radiofrequency obliteration (closure) versus ligation and vein stripping (EVOLVeS): two-year follow-up. Eur J Vasc Endovasc Surg 29 (2005) 67-73
37. Perala J., Rautio T., Biancari F., Ohtonen P., Wiik H., Heikkinen T., et al. Radiofrequency endovenous obliteration versus stripping of the long saphenous vein in the management of primary varicose veins: 3-year outcome of a randomized study. Ann Vasc Surg 19 (2005) 669-672
38. Viarengo L.M., Poterio-Filho J., Poterio G.M., Menezes F.H., and Meirelles G.V. Endovenous laser treatment for varicose veins in patients with active ulcers: measurement of intravenous and perivenous temperatures during the procedure. Dermatol Surg 33 (2007) 1234-1242
39. Theivacumar N.S., Dellagrammaticas D., Beale R.J., Mavor A.I., and Gough M.J. Fate and clinical significance of saphenofemoral junction tributaries following endovenous laser ablation of great saphenous vein. Br J Surg 94 (2007) 722-725
40. Proebstle T.M., Vago B., Alm J., Gockeritz O., Lebard C., and Pichot O. Treatment of the incompetent great saphenous vein by endovenous radiofrequency powered segmental thermal ablation: first clinical experience. J Vasc Surg 47 (2008) 151-156
41. Buller H.R., Agnelli G., Hull R.D., Hyers T.M., Prins M.H., and Raskob G.E. Antithrombotic therapy for venous thromboembolic disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126 (2004) 401S-428S
42. Stotter L., Schaaf I., and Bockelbrink A. Comparative outcomes of radiofrequency ablation, invagination stripping, and cryostripping in the treatment of great saphenous vein insufficiency. Phlebology 12 (2006) 60-64